(SABR) |
| 0 (0%) 10-10 07:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.95 |
| Resistance 1: | 1.85 |
| Pivot price: | 1.83 |
| Support 1: | 1.70 |
| Support 2: | 1.41 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.900 |
| Book Value | -4.610 |
| PEG Ratio | 0.00 |
| Gross Profit | 4.436 |
| Profit Margin (%) | -11.91 |
| Operating Margin (%) | 12.97 |
| Return on Assets (ttm) | 5.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 09 Oct 2025
Joe Y Chang: Who Needs Immunotherapy After SABR for Early-Stage NSCLC, and Who Does Not? - Oncodaily
Wed, 08 Oct 2025
Sabre (SABR): Buy, Sell, or Hold Post Q2 Earnings? - FinancialContent
Tue, 07 Oct 2025
Sabre (SABR) Strengthens Partnership with World Travel for Enhan - GuruFocus
Tue, 07 Oct 2025
10% YoY Growth: World Travel expands SabreMosaic multi‑year partnership to consolidate air, lodging and rail content - Stock Titan
Mon, 06 Oct 2025
Integrated chargeback platform: Sabre Direct Pay, Chargebacks911 unify issuing & acquiring workflows - Stock Titan
Mon, 06 Oct 2025
SABR Ties SOC Surgery in Non-Small Cell Lung Cancer Survival - Medscape
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
